IL17A and atherosclerosis: The primary 20 pathways were screened out based on p-value (p < 0.05) and predominantly included the PPAR signaling pathway, insulin resistance, lipid and atherosclerosis, the AMPK pathway, alcoholic liver disease, and the IL-17 pathway, among others.